Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Teva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple Sclerosis
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
MS related employment and disease modifying treatment in the German working population: 1994-2009.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
MS and NMO: Partners No More.
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine).
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis.
Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis.
Long-term effects of dalfampridine in patients with multiple sclerosis.
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
HERV-W envelope protein inhibits oligodendroglial precursor cell differentiation.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
Autoimmune myelopathies.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
Patient page. Multiple sclerosis and vitamin D.
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.
Motor impairments at presentation of clinically isolated syndrome suggestive of multiple sclerosis: Characterization of different disease subtypes.
Lodonal/LDN

Pages